tiprankstipranks
Trending News
More News >
Sutro Biopharma (STRO)
:STRO
US Market

Sutro Biopharma (STRO) Income Statement

Compare
671 Followers

Sutro Biopharma Income Statement

Last quarter (Q4 2024), Sutro Biopharma's total revenue was $14.81M, a decrease of -86.98% from the same quarter last year. In Q4, Sutro Biopharma's net income was $-72.44M. See Sutro Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 62.04M$ 153.73M$ 67.77M$ 61.88M$ 42.72M
Gross Profit
$ 62.04M$ 146.91M$ 59.48M$ 52.11M$ -34.24M
Operating Expenses
$ 300.50M$ 243.01M$ 196.72M$ 160.40M$ 113.78M
Depreciation and Amortization
$ 7.22M$ 6.82M$ 8.29M$ 9.77M$ 4.30M
EBITDA
$ -186.81M$ -67.92M$ -105.07M$ -98.52M$ -23.75M
Operating Income
$ -238.45M$ -89.28M$ -128.94M$ -98.52M$ -71.06M
Other Income/Expenses
$ 13.36M$ 677.00K$ 12.24M$ -7.01M$ 38.93M
Pretax Income
$ -225.10M$ -88.60M$ -116.70M$ -105.54M$ -32.13M
Net Income
$ -227.46M$ -106.79M$ -119.20M$ -108.67M$ -36.20M
Per Share Metrics
Basic EPS
$ -2.96$ -1.78$ -2.35$ -2.36$ -1.11
Diluted EPS
$ -2.96$ -1.78$ -2.35$ -2.36$ -1.11
Weighted Average Shares Outstanding
76.83M 60.16M 50.74M 46.12M 32.57M
Weighted Average Shares Outstanding (Diluted)
76.83M 60.16M 50.74M 46.12M 32.57M
Currency in USD

Sutro Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis